Still waiting for your reasons for doubting MSB management, rather than your subjective generalisations.
I'm still waiting for his/her detailed research report on shorting biotechs which was supposed to be being prepared in conjunction with an economist.
Where is it? Been waiting months and months.
Like most of madamswrs' assertions, they are made with little or no foundation, doubt is left to fester, and then he or she moves onto the next vague, generalised assertion.
He or she will not engage in specifics in relation to MSB.
When pressed he or she simply disappears for awhile and starts again.
Not sure how much respect is due for that.
(btw it was me who started the 'adam' thing, when I made a typo and left out the M from madamswr in a reply due to sticky keyboard.
He or she now runs with calling him/self 'adam'. It's some kind of little in joke.
Not sure how much respect is due for that either)
MSB Price at posting:
$4.37 Sentiment: Buy Disclosure: Held
(20min delay)